NCT02608918已完成1 期
An Open-Label Taste Assessment of BMS-955176 in Healthy Subjects
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- Taste properties of HIV Inhibitor will be measured using the Flavor Profile of the Flavor Leadership Criteria
研究概览
简要总结
The purpose of the study is to assess the taste properties of HIV inhibitor
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Men and women of non-childbearing potential professional sensory panelists
- •Aged between 25 and 80 years
排除标准
- •History of relevant drug or food allergies, cardiovascular or Central nervous system (CNS) disease, clinically significant pathology, history of mental illness
- •Positive HIV test
研究组 & 干预措施
BMS-955176
Experimental
BMS-955176 specified dose on specified days
干预措施: BMS-955176 (Drug)
结局指标
主要结局
Taste properties of HIV Inhibitor will be measured using the Flavor Profile of the Flavor Leadership Criteria
时间窗: Up to 2 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Taste Assessment of BMS-986165 in Healthy ParticipantsHealthy ParticipantsNCT03751228Bristol-Myers Squibb9
已完成
不适用
A Taste Assessment of Iberdomide and Mezigdomide in Healthy ParticipantsHealthy ParticipantsNCT05539976Bristol-Myers Squibb10
已完成
1 期
A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule FormulationHealthyNCT02006277Pfizer21
已完成
1 期
Taste Properties of Atazanavir and CobicistatHIV in AdultsNCT02307656Bristol-Myers Squibb6
已完成
1 期
Raltegravir Insulin Sensitivity StudyHIV InfectionsNCT00531999St Stephens Aids Trust18